Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 21

The Feasibility and Acceptability of Culturally Appropriate Pulmonary Rehabilitation for Adults with Chronic Obstructive Pulmonary Disease in Sri Lanka: Randomized Controlled Trial

Authors Jayamaha AR ORCID logo, Perera CH ORCID logo, Orme MW ORCID logo, Karunatillake RDS, Fernando A, Barton A, Steiner MC ORCID logo, Matheson J, Manifield J, Barradell AC ORCID logo, Chathurantha S, Dias RR ORCID logo, Amarasekara TD ORCID logo, Wimalasekera SW, Singh SJ ORCID logo

Received 8 March 2025

Accepted for publication 9 March 2026

Published 30 April 2026 Volume 2026:21 527013

DOI https://doi.org/10.2147/COPD.S527013

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Richard Russell



Akila R Jayamaha,1,2 Chamilya H Perera,1,2 Mark W Orme,2,3 Ravini De S Karunatillake,4 Amitha Fernando,4 Andy Barton,2,3 Michael C Steiner,2,3 Jesse Matheson,5 James Manifield,2,3 Amy C Barradell,2,3 Suresh Chathurantha,4 Ruwin R Dias,6 Thamara D Amarasekara,7 Savithri W Wimalasekera,8 Sally J Singh2,3

1Faculty of Nursing, KIU, Colombo, Sri Lanka; 2Department of Respiratory Sciences, University of Leicester, Leicester, UK; 3Centre for Exercise and Rehabilitation Science, University Hospitals of Leicester NHS Trust, Leicester, UK; 4Central Chest Clinic, National Hospital of Sri Lanka, Colombo, Sri Lanka; 5Department of Economics, University of Sheffield, Sheffield, UK; 6Faculty of Music, University of Visual and Performing Arts, Colombo, Sri Lanka; 7Faculty of Allied Health Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka; 8Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka

Correspondence: Akila R Jayamaha, Department of Respiratory Sciences, University of Leicester, Leicester, UK, Email [email protected]; [email protected]

Purpose: Pulmonary rehabilitation (PR) is recommended internationally for individuals with chronic obstructive pulmonary disease (COPD), but there is limited evidence and practice of PR in Sri Lanka. Key challenges for PR such as poor accessibility, uptake and completion need to be addressed when designing and delivering new PR programmes. Accordingly, this study determined the feasibility and acceptability of culturally adapted PR for adults with COPD in Sri Lanka.
Patients and Methods: A randomized controlled feasibility trial was conducted with 50 adults living with COPD in Colombo, Sri Lanka. A culturally adapted PR comprised a 6-week rolling programme with sessions conducted twice every week. Sessions involved endurance and resistance exercise training, education and cultural adaptations of nutritional support and group singing. The control group received usual care, which did not include any form of PR or exercise training. Feasibility was determined by uptake (≥ 60% of eligible participants consented) and completion (≥ 70% of recruited participants). Acceptability was explored by focus group discussions (FGDs) analysed thematically.
Results: Seventy-nine eligible individuals (94% of screened) were referred in order to recruit 50 participants (63% uptake). The majority of participants in both intervention (72%, n=18) and control (64%, n=16) groups completed the study. Based on qualitative focus group discussions four themes emerged: (1) Increased knowledge following PR, including dispelling misbeliefs about COPD and improving medication adherence; (2) Perceived improvements in health following PR, including improved walking ability and reduced breathlessness (3) Enjoyment and benefits of cultural adaptations to PR, and (4) Challenges during PR, including adherence to exercise and travel requirements.
Conclusion: Culturally adapted PR was feasible and acceptable to adults with COPD in Sri Lanka. A fully powered trial is warranted for evaluating clinical and cost-effectiveness of culturally adapted PR.

Keywords: COPD, culturally adapted PR, Colombo Sri Lanka, practicality, suitability

Introduction

Accounting for 3.3 million deaths annually, chronic obstructive pulmonary disease (COPD) is ranked as the third-leading cause of death and the seventh-leading cause of poor health worldwide.1 The impact of COPD on individuals, families and society urges the need for evidence-based interventions to address the associated disability.2

PR reduces symptom burden, improves health status and quality of life of individuals living with COPD in high-income countries.3,4 Even though international guidelines (informed predominantly from evidence in high-income countries) recommend PR as an essential component of COPD management.5–7 There is limited evidence and clinical practice of PR in low- and middle-income countries,8 including Sri Lanka, which did not have a recognized PR service at the time of this trial. A non-randomised feasibility trial of PR has been reported conducted in Jaffna, Sri Lanka,9 and India, where peer support was employed in community-based centres.10 Other trials are currently being conducted in a post TB lung disease population in Uganda11 and Kyrgyzstan12 which will add to the body of knowledge previously reported in a systematic review describing low-quality evidence for PR8 in a low resource setting.13 The previously reported trial in Sri Lanka was not culturally adapted for the Sri Lankan population, which is an important consideration. Even in parts of the world where PR is routinely practiced, poor accessibility, uptake and completion remain challenging, with less than 3% of eligible patients with chronic lung disease estimated to have access to PR globally, suggesting that a one-size-fits-all approach is not appropriate for every population.14

Patient-centred approaches are needed to inform potential adaptations to PR, which may enhance the appeal of PR whilst still incorporating the essential components of PR.15 Our previous survey study revealed a clear patient preference for supervised hospital-based PR9 and a previously reported qualitative study proposed local adaptations for Sri Lankan adults with COPD, including nutritional supplementation with “Samaposha®”, singing to facilitate breathing control, the use of music in classes to boost enjoyment, and prioritising education topics of symptom management, nutritional advice, and use of medication.16 Accordingly, this study aimed to determine the feasibility and acceptability of a culturally adapted PR programme for adults with COPD in Sri Lanka.17

Materials and Methods

Study Design and Registration

A single-blind randomized controlled feasibility trial was conducted in adults living with COPD to compare culturally adapted PR with usual care. Ethical approval for the study was obtained from research ethics committee of Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka (FMS/USJP ERC 64/19) and the University of Leicester, United Kingdom (26770). The study protocol has been published previously17 and the trial was prospectively registered (ISRCTN13367735). All participants provided written informed consent prior to participation.

This manuscript has been written in accordance with the Template for Intervention Description and Replication (TIDieR)18 (supplementary material 1) and CONsolidated Standards Of Reporting Trials (CONSORT)19 guidelines (supplementary material 2).

Study Site

This study was conducted at Central Chest Clinic (CCC), Colombo, Sri Lanka, a state-owned healthcare facility that provides treatment for adults with respiratory diseases. The recruitment of participants commenced in September 2022 and closed in March 2023, with the study completed in June 2023.

Participants

A formal sample size calculation was not performed due to the feasibility nature of the trial.20 Our recruitment target of 50 participants (25 in each group) is in line with previous randomized controlled PR trials for patients with COPD.21 Medical officers and nurses in CCC referred the adults living with COPD who were screened for eligibility. The inclusion criteria involved adults aged ≥18 years with a clinically confirmed diagnosis of COPD by a physician confirmed by spirometry based on GOLD criteria with FEV1/FVC<0.7, and FEV1<80% predicted (lung function was taken from medical records due to COVID-19 pandemic restrictions preventing spirometry being conducted as part of the trial), ≥1 exacerbation required hospitalisation in the year preceding the study, a Medical Research Council (MRC) dyspnoea grade ≥2,22 and able to give informed consent. Adults with comorbidities such as severe or unstable cardiovascular disease, malignant disease, locomotor difficulties, or other serious illnesses that preclude exercise were excluded from the study.

Randomisation

An individual, independent of the research team, randomized participants (1:1) into either the intervention group or control group using Sealed Envelope.23

Blinding

Due to the nature of PR, it was not possible to blind participants to their group allocation. Outcome assessors were blinded and participants were instructed not to reveal their group allocation during the discharge assessment. The blinded outcome assessors were also advised to report and document any episode of unblinding.

Trial Intervention

Intervention: Culturally Adapted Pulmonary Rehabilitation

Culturally adapted PR was delivered over 6-week period, consisting of 12 sessions in total (2 sessions per week). This intervention was developed and conducted in accordance with published quality standards for PR5,24 and was delivered as face-to-face group sessions (groups consisted of 4–6 adults with COPD) by multidisciplinary team of physiotherapists, nurses and doctors. Each session lasted approximately 2 hours comprising the core elements of evidence-based rehabilitation, with 1 hour supervised exercise training, 40 minutes education session and 20 minutes group singing. All PR components followed international guidelines.5,7

Exercise training comprised warm-up exercises, aerobic training (individually prescribed walking speed and duration), strength training (upper limb exercises such as bicep curls and dumbbell upright row, and lower limb exercises such as step-ups, sitting and standing) using minimal equipment8 (dumbbells, plastic steps, Therabands), and warm down exercises. Walking speed was individually prescribed from the incremental shuttle walking test (ISWT), equivalent to 85% maximal oxygen capacity (VO2 peak). The patients were asked to walk 20 minutes at the prescribed speed, and if they were unable to continue for the entire duration, they were asked to stop to catch their breath before continuing. Over the course of the programme, participants were encouraged to aim towards walking the entire 20 minutes without stopping. Participants were asked to follow their walking exercise prescription at home on days without a scheduled PR session. Strength training was individually prescribed considering the 70% of one repetition maximum and progressed by adjusting the number of repetitions (1 to 2 sets of 8 to 12 repetitions) or the weight of the dumbbells (increasing by 0.5 kg, when the participant is able to perform 2 sets of 12 repetitions with prescribed weight) during the programme. Participants were instructed to perform one additional strength training session at home each week using minimal equipment (eg, filled water bottles as dumbbells). Education sessions were delivered by an interdisciplinary team consisting of investigators, medical officers, nurses, physiotherapists and nutritionists. Education topics included avoidance of exacerbations, chest clearance, diet, exercise, maintaining the benefit after PR, and pharmacy. All the education sessions and the instructions during PR were provided in Sinhala language as convenient for the participants.

Each group singing component consisted of a 5-minute warm-up, 10 minutes of singing followed by a 5-minute warm-down.16 The group singing component was specifically delivered by a trained Sri Lankan musician with experience delivering singing exercises to enhance better breathing. Participants selected songs and used the provided musical instruments to help maintain the rhythm and pace and to enhance the musical experience.

A personalised diet plan was developed by a trained, registered nutritionist (CP) for each participant. This was based on individuals’ nutritional status which was assessed prior to the beginning of PR via seven-day diet diary and body composition assessment using bio electrical impedance. A dietary supplementation, “Samaposha®”, consisting of a mixture of protein containing grains with similar content of nutrients of supplementation which is provided for pregnant mothers, underweight children and TB patients by the government was included as a daily component to their personalised diet plan and was monitored, via dietary logs, and adjusted accordingly throughout the intervention period.

Usual Care

Usual care consisted of pharmacological treatment and optimization, prescribed to patients after consultation with medical officers at the CCC. Brief information about disease conditions, medication and inhaler techniques was provided by medical officers and nurses. PR or any form of exercise training was not a part of conventional care. The participants allocated to the control group did not receive any scheduled contact, follow-up, or attention during 6-week intervention period and they were contacted after 6-weeks, only for scheduling the discharge assessment.

Data Collection and Management

Data were collected in accordance with the recommended international dataset for PR trials across LMICs.21 All the scales were translated into Sinhala language, following the two-stage RECHARGE translational protocol (adapted from translation protocol for the Severe Asthma Questionnaire25) which included translation and back translation by two individual bilingual speakers. Collected data were entered into a Research Electronic Data Capture (REDCap) database, via a secure password protected web-interface.21 The records of the participants were identified by the trial identity number. Qualitative data were managed using Microsoft Word and Microsoft Excel.

Feasibility Outcomes

The primary outcomes of the study were the feasibility of culturally adapted PR in a low-resource Sri Lankan healthcare setting. Measures to assess feasibility are outlined in detail within our previously published protocol17 and focused on uptake and completion. Similar to other PR feasibility trials,26 traffic light system progression criteria (Red-Amber-Green (RAG)) was used, where green indicated the feasibility of trial using the current methodology (recruitment ≥60%, completion ≥70%); amber indicated the need of modifications in the methodology (recruitment – 25–59%, completion – 50–69%) and red indicated non-feasibility of the trial (recruitment <25%, completion <50%),19,26,27 the trial was considered feasible in its current form if ≥60% of eligible participants consented to take part in the study (uptake) and if ≥70% of recruited participants randomised into the PR group attended ≥75% [9/12] sessions and the discharge assessment.

Acceptability

The experience of participants who completed the PR programme were explored via focus group discussions (FGDs) after their discharge assessment. These discussions mainly focused on perception of PR, perceived benefits, barriers, challenges and recommended changes to the programme. Discussions were facilitated by a trained researcher (CP) in Sinhala language, translated to English to facilitate analysis. All discussions were audio recorded (SONY ICD-UX570F recorder) with the permission of the participants. Those who did not complete PR were invited to a drop-out interview and information divulged freely by the participants was recorded as field notes.

Secondary Outcomes

Secondary outcomes measured before starting the trial (baseline) and after completion of the trial (discharge) are outlined in detail elsewhere.17 In order to facilitate the comparison across other studies and international benchmarking, selected outcomes were informed by our previous work9 and agreed across the wider Global RECHARGE group.21 Further, we used multiple questionnaires and field walking tests which are commonly used in COPD and PR literature which included: MRC dyspnoea grade, COPD Assessment Tool (CAT), Clinical COPD Questionnaire (CCQ), Work Productivity and Activity Impairment (WPAI), Euro-QOL (EQ-5D-5L), Hospital Anxiety and Depression Scale (HADS), Incremental and Endurance Shuttle Walk Tests (ISWT and ESWT), in accordance with the minimum dataset for PR in LMIC.21 Two ISWTs were conducted at baseline to reduce the learning effect. The minimal clinically important differences (MCID) for aforementioned outcomes were: MRC score: 1 point;28,29 CAT: 2 points;28 HADS: 2 points;29,30 CCQ: 0.4 points;31 EQ5D-5L VAS: 7 points;32 ISWT: 35m;33 ESWT: 174s;34 5x sit to stand test: 1.7s.35

Patient and Public Involvement (PPI)

Adults living with COPD and their family caregivers were involved in the design of the PR programme, including mode of delivery (group based, supervised PR in hospital setting), structure (biweekly 2-hour sessions) and tailoring the culturally adapted PR programme (incorporating group singing, contents of education sessions and dietary supplementation with “Samaposha®”) via survey9 and/or qualitative interviews.16 Informal PPI discussion then refined the implementation of new components in practice.

Data Analysis

Of 50 randomised adults with COPD, 34 (18 participants within the PR group, and 16 in the control group) were considered for data analysis. Quantitative data were presented descriptively using IBM SPSS Statistics for Windows (version 28.0). The normality of the variables was assessed with Shapiro Wilks test. The normally distributed data were presented as means ± standard deviations and skewed data presented as median (interquartile range). No inferential statistics or imputation were conducted due to the feasibility nature of the study and the difference of pre and post mean values compared against the relevant MCIDs using descriptive statistics.

Qualitative data were analyzed using codebook thematic analysis by following six steps (i) Familiarization with the data (CP, ARJ, JM, MO); (ii) Coding the data, semantic and inductive coding approaches were adopted (CP, ARJ, JM, MO); (iii) Generating initial themes (CP, ARJ, JM, MO); (iv) Reviewing and developing themes (CP, ARJ, JM, MO, TA); (v) Refining, defining and naming themes (CP, ARJ, JM, MO, TA, AB); and (vi) Producing the report (CP, JM, MO). Microsoft Excel and Microsoft Word were used for the data management and analysis.

Results

Feasibility: Screening and Recruitment

Eighty-four adults with COPD were screened for eligibility, of which 79 (94%) were referred to the study (Figure 1). Of these, 29 were not interested in participating, leaving 50 participants (63% of eligible) who attended the baseline assessment, consented and randomised into two groups, allocating 25 participants for each.

CONSORT diagram of COPD study with 84 assessed, 50 randomized and follow-up details.

Figure 1 CONSORT diagram.

Seven participants allocated for the intervention group were lost to follow-up. Family members refused to send for PR (n = 1), diagnosed with bundle branch block (n = 1), found new employment (n = 2), transportation difficulties owing to change of residence (n = 1) and unrelated death of the participant (n = 1) were the causes for the dropouts from PR. Of the participants who attended all PR sessions, one underwent emergency bypass surgery and could not complete the post assessment. Nine participants allocated to the control group were refused to give an appointment for the post assessment and two were unreachable.

Demographic Characteristics

Intervention and control groups were generally well matched (Table 1). The majority of participants were Sinhala, Buddhist, married, and males, with a mean age of 65±8 years. One difference occurring by chance was the proportion of participants in paid work, with 8% (n = 2) of the intervention group and 48% (n = 12) of the control group; translating into the intervention group having a lower average household income.

Table 1 Participant Baseline Characteristics

Feasibility: Completion

Overall, 34 participants (68% of recruited) attended the follow-up assessment (Figure 1) with 7 participants within the PR group, and 9 in the control group being lost to follow-up. Eighteen participants (72%) in the intervention group attended 9/12 PR sessions and completed the discharge assessment (“completer”). Eighteen participants from PR group and 16 from control group were considered as intervention completers (Figure 1, Table 2).

Table 2 Comparison of Demographic Characteristics Between Trial Completers and Non-Completers

Acceptability

Four FGDs were conducted among 18 participants (4–5 participants per FGD) who completed the PR programme. Four themes were generated from the data (Table 3).

Table 3 Generated Themes with Illustrative Quotes

Theme 1: Increased Knowledge Following PR

Participants expressed their positive experiences about the education component, which included improving knowledge on symptom management, improving physical activity and nutrition, controlling exacerbations and maintaining quality of life. Many participants initially had misbeliefs such as COPD spreading via droplets, which were corrected and clarified as part of the educational component of PR. With the acquired new knowledge and enhanced understanding by correcting false beliefs from the education component of PR, participants reported how they have made improvements relating to symptom self-management, more appropriate usage and better understanding of their medications, physical activity, and healthy eating following PR as their behavioral changes. These changes have made a positive impact on their lifestyle and more adherence to the PR.

Theme 2: Perceived Improvements in Health Following PR

Participants reported improvements in their walking ability and daily activities. Specifically, they reported an ability to walk further with reduced sensations of breathlessness following PR. They also noticed a reduction in breathing difficulty and phlegm production, contributing to an overall sense of better quality of life. Participants felt positive about continuing their PR independently beyond the intervention and were keen to recommend the PR programme to other people.

Theme 3: Enjoyment and Benefits of Cultural Adaptations to PR

The singing component was deemed a pleasurable activity for participants as it helped them to control their breathing while reducing their discomfort and breathlessness. Several participants talked about how they continued the signing activities outside of the scheduled PR sessions and that they will continue to do so beyond their trial participation.

Participants were highly satisfied with the supplementation and the dietary adaptations within their individualized diet plans. They reported dietary changes and such as increased intake of healthy and nutritious foods which they felt contributed to their health improvements and reduced symptom burden.

Theme 4: Challenges During PR

During the PR programme, there were very few barriers identified by participants. Several participants reported difficulty in adopting the exercise recommendations as they felt tired and had difficulty in moving their extremities. One participant mentioned that the provided supplementation was shared with the family members, which lowers the intake than the recommended amount. Unavailability of PR in other clinic settings was raised as a concern, particularly in relation to the travel required to attend PR.

Secondary Outcomes

Clinically meaningful changes were observed after PR for the MRC score, CCQ mental score, CAT score, HADS depression score, HADS anxiety score, EQ5D-5L perceived health, and ISWT distance. Improvements of the usual care group were also observed for CCQ mental score, HADS depression score, and ISWT distance (Table 4). All secondary outcome data were completed by those who completed PR, except ESWT. As per the RECHARGE protocol, two ISWTs and one ESWT were conducted at the baseline and discharge and at least 30 minutes rest between tests. A second visit was scheduled for the ESWT, which resulted in 12 participants (3 controls, 9 PR) at baseline assessment, 4 participants (4 controls, 0 PR) at discharge assessment refused to participate in ESWT.

Table 4 Comparison of Baseline Assessment and Post-Intervention Assessment Between Intervention Completed Group and Control Completed Group

Adverse Events and Safety of the Intervention

The culturally adapted PR was reported as a safe intervention, evidencing no directly attributed adverse events reported during or after the PR sessions. None of the adults with COPD who completed the culturally adapted PR (n = 18) reported exacerbations or hospitalisations during the 6-week intervention period. A death was also reported following an accidental fall outside of the rehabilitation programme, which was deemed unrelated to the PR.

Discussion

In this first trial of culturally adapted PR in Sri Lanka for adults with COPD, incorporating singing, music and personalised nutritional plan, it was feasible to recruit (63%; target ≥60%) and retain (PR: 72% and control: 64%; target ≥70%) participants. FGDs found that culturally adapted PR was acceptable for Sri Lankan adults with COPD. Participants reported enjoying the cultural components of PR (incorporating singing, nutritional supplementation and individualized diet therapy with local foods) as well as perceived improvements to their walking ability, respiratory symptoms and knowledge. Key challenges during PR related to adhering to the personalised exercise prescription and the burden of travel to attend PR classes.

Uptake in PR during the present study was greater than that observed by the only other study of PR in Sri Lanka, a single-arm non-randomised trial in Jaffna, which saw 56% of participants attend the baseline assessment.13 As many referred adults with COPD within this previous trial declined to participate due to lack of interest, one reason for the greater uptake in the present study may relate to PR catering to cultural diversity in its offering and delivery.36,37 When the PR is culturally adapted, participants feel familiar, comfortable and inclusive.38 All the adaptations of the current study were informed during the prior qualitative work among Sri Lankan adults with COPD, their caregivers and healthcare professionals.39 Selected adaptations were well grounded in Sri Lankan culture, ie. singing is deeply woven into Sri Lankans’ daily living, not only as a recreational activity but from lullaby to death rituals. Similar cereal supplementation to “Samaposha ®” is usually provided by the Sri Lankan government to every underweight child during early childhood, to every woman during the pregnancy period and even to patients with tuberculosis.

In contrast, participants feel discouraged to uptake, adhere and complete when the PR is culturally alien or unsafe40. A recent systematic review on self‑management interventions on COPD in LMICs in Asia supported our argument by concluding that the context-specific adaptations are mandated and the interventions should be tailored to cater to the local needs41. Findings from the focus group discussions also suggested that participants enjoyed the addition of a culturally adapted singing component, which likely contributed to improve participation and PR completion of Sri Lankan adults with COPD. Our culturally adapted hospital-based PR feasibility study also demonstrated superior completion rates compared to feasibility studies on PR modalities such as Community-Based PR (only 33% of recruited participants completed at least 75% of sessions and attended the post-intervention assessment).26 Further, a feasibility study conducted in economically deprived areas of Jodhpur in neighbouring India concluded that community-based PR was not feasible26 following the same RAG criteria. Interestingly, the completion rate of the current study was higher than (72% vs 43%) the non-blinded, randomised feasibility trial of an adapted PR conducted in Georgia (upper-middle-income country).42 The uptake and completion rates to PR within our study were similar to those reported in high-income countries. For example, according to NRAP Breathing Well Report 2024, almost a third (32%) of adults with stable COPD referred to PR started within 90 days and 68% (72% in the present study) of adults with COPD completed PR.43 These findings are reflective by the positive qualitative feedback from participants completing PR. Therefore, in a setting with limited prior PR exposure, it was possible to deliver a PR programme attractive to patients, with completion rates in keeping with countries with established PR services.

Although not powered to detect changes in clinical outcomes, this study found promising improvements within the PR group, surpassing published MCIDs for COPD. Specifically, these included reduced breathlessness, anxiety, and depression scores, along with improved health-related quality of life and exercise capacity. Combined with the high uptake and completion of PR as well as the positive experiences of PR attendees in the present study, our findings support and encourage further work to expand the evidence base for PR in Sri Lanka and other parts of the world without established PR programmes,8,44 including fully powered RCTs to confirm effectiveness and cost-effectiveness.

There are, however, several challenges still to be overcome. Participants who were unable to participate in the present study cited their employment responsibilities, physical inability to travel to PR appointment and already being satisfied with medical management of their COPD as key reasons not to engage with PR; in line with previous work.13 Due to the CCC seeing patients from across Sri Lanka, the finance cost of some patients to attend PR classes running twice weekly for six weeks (requiring unpaid leave) combined with the need to travel long distances to attend PR were particularly pertinent barriers. As the evidence base for PR grows in Sri Lanka, so will the need to establish appropriate PR centres across the country, with additional modes of PR delivery (eg, home-based programmes) to improve the accessibility of PR.45–47

Several limitations must be considered. Due to the nature of the PR intervention, it was not possible to blind participants to their allocation. To address this, participants were only informed of their allocation upon completion of their baseline assessment. After randomisation, a mismatch of household income pertaining to employment was observed between intervention group and control group. PR literature evinces that the financial constraints negatively impact PR participation and completion.48 A higher percentage of completion rate was shown in the intervention group while financial superiority was observed in the control group. Selecting a homogeneous sample49 (using block randomisation50), large enough51 to detect a statistically and clinically meaningful difference in outcomes between intervention and control groups, consider objectively assessable outcome measures and MCIDs validated to the relevant population, conducting a multicenter study to improve generalizability and including 6-months or 1-year post PR assessment to determine whether the acquired outcomes are maintained at a longer-term are recommended for designing a future fully powered RCT. The improvements of few health parameters were also observed in the control group; the changes in HRQOL, psychological well-being and the MRC score were of a much lower magnitude than observed in the intervention group, and consistently below the MCID unlike the intervention group. However, the results from the exercise test data were unexpected. We are confident there was no contamination of the groups, and the testers were blinded and would need larger study to understand this observation. We know from previous work that simply conducting an exercise test can improve performance but this seems an unlikely explanation.52

Participants were recruited solely from the CCC in the Colombo district of Sri Lanka and may not be generalisible to other parts of the country. Scalability challenges attributed to the cultural adaptations such as need of trained musicians can be prevented using recorded standard operating procedure of singing sessions or nutritional supplementation with “Samaposha®” can be replaced with similar locally available cereal. Suitability of proposed cultural adaptions should be explored with preliminary qualitative studies with patients and health care professionals in own precinct. However, our approach of developing a culturally appropriate PR programme can be transferred to other settings, within Sri Lanka and in parts of the world with established clinical PR services.

Conclusion

Culturally adapted pulmonary rehabilitation using minimal equipment, including group singing and nutrition supplementation, was feasible in a low resource Sri Lankan health care setting and was acceptable for adults with COPD. The current study, as the first culturally adapted PR trial in Sri Lanka with superior uptake and completion rates, further emphasises that PR should be tailored to cater to the cultural needs, especially in LMICs with limited resources and cultural diversity.

A fully powered trial (a large-scale RCT with a homogeneous sample adequate to reliably detect a statistically and clinically meaningful difference in exercise capacity [ISWT] and psychological health [CCQ mental score, HADS], including 6-month or 1-year post PR assessment) is needed to determine the clinical and cost-effectiveness of this intervention within this context.

Data Sharing Statement and Ethical Consideration

This study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent including consent for publishing anonymised responses and direct quotes.

All data will be stored safely for up to 6 years and after 6 years consent form and data sheets will be disposed of appropriately. Upon reasonable request to the corresponding author, anonymised data from the Global Health Research Group on Respiratory Rehabilitation (Global RECHARGE) Core Dataset 21 will be made available following the completion of this project.

Acknowledgments

Authors wish to acknowledge all the adults with COPD who participated in the study and T. Weerasinghe, M. Kumara, A. Kariyawasam, D. Rishwana, S. Deshapriya, T. Premakumara, D. Ruwanpathirana, A. Manel, D. Wijesena and all the health care professionals at Central Chest Clinic, Colombo for their invaluable contribution during the PR execution and acquisition of study data. We would like to express my gratitude to the Centre for Exercise and Rehabilitation Science (CERS) team at Glenfield Hospital, UK, for providing training on pulmonary rehabilitation.

The abstract of this paper was presented at the European Respiratory Society International Congress 2023 as a poster presentation with interim findings. The poster’s abstract was published in “Poster Abstracts” in European Respiratory Journal: https://doi.org/10.1183/13993003.congress-2024.PA3177.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the International Journal of Chronic Obstructive Pulmonary Disease, which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

This randomized control feasibility trial was funded by the National Institute for Health Research (NIHR) (17/63/20) using UK aid from the UK Government to support global health research. The author(s) divulged receipt of financial support for the research, authorship, and/or publication of this article. Professor Singh is a NIHR Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Momtazmanesh S, Moghaddam SS, Ghamari SH, et al. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59(10). doi:10.1016/j.eclinm.2023.101936

2. Singh SJ, Halpin DMG, Salvi S, Kirenga BJ, Mortimer K. Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunities. Lancet Respir Med. 2019;7(12):1002–16. doi:10.1016/S2213-2600(19)30364-9

3. Yang J, Lin R, Xu Z, Zhang H. Significance of pulmonary rehabilitation in improving quality of life for subjects with COPD. Respir Care. 2019;64(1):99–107. doi:10.4187/respcare.06353

4. Mccarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2015(2). doi:10.1002/14651858.CD003793.pub3

5. Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2023;208(4):e7–e26. doi:10.1164/rccm.202306-1066ST

6. GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2026 REPORT); 2026. Available from: www.goldcopd.org. Accessed April 11, 2026.

7. Man W, Chaplin E, Daynes E, et al. British thoracic society clinical statement on pulmonary rehabilitation. Thorax. 2023;78(5 S):2–15. doi:10.1136/thorax-2023-220439

8. Habib GM, Rabinovich R, Divgi K, et al. Systematic review of clinical effectiveness, components, and delivery of pulmonary rehabilitation in low-resource settings. NPJ Prim Care Respir Med Nature Res. 2020;30(1). doi:10.1038/s41533-020-00210-y

9. Perera ACH, Jayamaha AR, Jones AV, et al. Developing appropriate pulmonary rehabilitation services in Sri Lanka: assessment of people living with COPD and healthcare providers in urban and semi urban areas in Sri Lanka. Int J COPD. 2022;17:631–641. doi:10.2147/COPD.S316555

10. Jebaraj P, Paul B, Isaac R, et al. Optimising participation in a pulmonary rehabilitation programme for people living with chronic respiratory diseases in rural India: a feasibility study. J Glob Health. 2025;15. doi:10.7189/jogh.15.04143

11. Katagira W, Orme MW, Kasiita R, et al. Clinical Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation for People in Uganda with Post-TB Lung Disease: A Randomized Controlled Trial. Chest. 2026. doi:10.1016/j.chest.2025.12.057.

12. Akylbekov A, Orme MW, Matheson JA, et al. Clinical and Cost-Effectiveness of Pulmonary Rehabilitation for People with Post-Tuberculosis Lung Disease in Kyrgyzstan: A Single-Blind Randomized Controlled Trial. Ann Am Thorac Soc. 2026:aaoag062. doi:10.1093/annalsats/aaoag062

13. Sooriyakanthan M, Orme MW, Sivapalan K, Selvaratnam G, Singh SJ, Wimalasekera S. A feasibility trial of pulmonary rehabilitation for patients with COPD in a low resource setting: jaffna, Sri Lanka. BMC Pulm Med. 2022;22(1):1–9. doi:10.1186/s12890-022-02092-x

14. Lahham A, Holland AE. The need for expanding pulmonary rehabilitation services. Life. 2021;11(11):1–11. doi:10.3390/life11111236

15. Holland AE, Singh SJ, Casaburi R, et al. Defining modern pulmonary rehabilitation: An official American thoracic society workshop report. Ann Am Thorac Soc Am Thoracic Soc. 2021;18(5):E12–E29. doi:10.1513/AnnalsATS.202102-146ST

16. Perera C, Yusuf Z, Jayamaha A, et al. Development of Culturally Appropriate Pulmonary Rehabilitation (PR) for Sri Lanka: a qualitative study. Eur Respir J. 2021;58:PA3904. doi:10.1183/13993003.congress-2021.PA3904

17. Jayamaha AR, Perera CH, Orme MW, et al. Protocol for the cultural adaptation of pulmonary rehabilitation and subsequent testing in a randomised controlled feasibility trial for adults with chronic obstructive pulmonary disease in Sri Lanka. BMJ Open. 2020;10(11):1–11. doi:10.1136/bmjopen-2020-041677

18. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348(March):1–12. doi:10.1136/bmj.g1687

19. Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355. doi:10.1136/bmj.i5239

20. Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057–1073. doi:10.1177/0962280215588241

21. Orme MW, Free RC, Manise A, et al. Global RECHARGE: establishing a standard international data set for pulmonary rehabilitation in low- and middle-income countries. J Glob Health. 2020;10(2). doi:10.7189/JOGH.10.020316

22. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.580

23. Singh J. Randomization and online databases for clinical trials. J Pharmacol Pharmacother. 2014;5(2):173–174. doi:10.4103/0976-500X.130155

24. British Thoracic Society Quality Standards for Pulmonary Rehabilitation in Adults. 2014. Available from: https://www.brit-thoracic.org.uk/guidelines-. Accessed April 11, 2026.

25. Hyland ME, Jones RC, Lanario JW, Masoli M. The construction and validation of the severe asthma questionnaire. Eur Respir J. 2018;52(1). doi:10.1183/13993003.00618-2018

26. Thakor M, Singh V, Manifield J, et al. Community-based pulmonary rehabilitation in an economically deprived area of Jodhpur, India: a mixed-methods feasibility trial. Int J COPD. 2025;20:473–478. doi:10.2147/COPD.S488766

27. Herbert E, Julious SA, Goodacre S. Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials. Trials. 2019;20(1). doi:10.1186/s13063-019-3578-y

28. Kon SSC, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-3

29. Smid DE, Franssen FME, Houben-Wilke S, et al. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc. 2017;18(1):53–58. doi:10.1016/j.jamda.2016.08.002

30. Wynne SC, Patel S, Barker RE, et al. Anxiety and depression in bronchiectasis: response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chron Respir Dis. 2020;17:1–9. doi:10.1177/1479973120933292

31. Kon SSC, Dilaver D, Mittal M, et al. The clinical COPD questionnaire: Response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014;69(9):793–798. doi:10.1136/thoraxjnl-2013-204119

32. Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500.

33. Evans RA, Singh SJ. Minimum important difference of the incremental shuttle walk test distance in patients with COPD. Thorax. 2019;74(10):994–995.

34. Zatloukal J, Ward S, Houchen-Wolloff L, Harvey-Dunstan T, Singh S. The minimal important difference for the endurance shuttle walk test in individuals with chronic obstructive pulmonary disease following a course of pulmonary rehabilitation. Chron Respir Dis. 2019;16:1479973119853828.

35. Jones SE, Kon SSC, Canavan JL, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax. 2013;68:1015–1020. doi:10.1136/thoraxjnl-2013-203576

36. Maddocks S, Camp P, Tang C. Engaging ethnically diverse populations in self-management interventions for chronic respiratory diseases: a narrative review. Pulm Ther. 2023;9(2):195–206. doi:10.1007/s41030-023-00218-y

37. Tang CY, Lavercombe M, Southcott AM, Taylor NF, Blackstock FC. Access to pulmonary rehabilitation for people from culturally and linguistically diverse communities: a cohort study. Health Soc Care Commun. 2022;30(6):e4133–e4143. doi:10.1111/hsc.13807

38. Alamer S, Robinson-Barellla A, Cooper M, Nazar H, Husband A. Barriers and facilitators of adherence to treatment interventions for COPD amongst individuals from minority ethnic communities: Meta-ethnography. PLoS One. 2025;20(2 February). doi:10.1371/journal.pone.0318709

39. Perera C, Jayamaha A, Orme M, et al. How to culturally adapt the pulmonary rehabilitation programme for people living with COPD in Sri Lanka: a qualitative study. BMJ Open Respir Res. 2025;12(1). doi:10.1136/bmjresp-2024-002407

40. Levack WMM, Jones B, Grainger R, Boland P, Brown M, Ingham TR. Whakawhanaungatanga: the importance of culturally meaningful connections to improve uptake of pulmonary rehabilitation by Māori with COPD - A qualitative study. Int J COPD. 2016;11(1):489–501. doi:10.2147/COPD.S97665

41. Adhikari S, Thapa S, Rattanapan C, Laosee O, Sriram S, Bhatta J. Evaluating the impact of self-management interventions on COPD outcomes in low- and middle-income countries in Asia: a systematic review. Health Qual Life Outcomes BioMed Central Ltd. 2025;23(1). doi:10.1186/s12955-025-02382-y

42. Maglakelidze M, Kurua I, Maglakelidze N, et al. Feasibility of a pulmonary rehabilitation programme for patients with symptomatic chronic obstructive pulmonary disease in Georgia: a single-site, randomised controlled trial from the Breathe Well Group. BMJ Open. 2022;12(9). doi:10.1136/bmjopen-2021-056902

43. National Respiratory Audit Programme. Breathing Well: an Assessment of Respiratory Care in England and Wales.; 2024. Available from: https://www.nrap.org.uk/NRAP/welcome.nsf/0/389995B692C7FC2480258B560065673C/$file/NRAP_Breathing_Well_Report_2024.pdf. Accessed January 4, 2025.

44. Bickton FM, Fombe C, Chisati E, Rylance J. Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis. 2020;24(10):991–999. doi:10.5588/IJTLD.19.0526

45. Bickton FM, Shannon H. Barriers and enablers to pulmonary rehabilitation in low-and middle-income countries: a qualitative study of healthcare professionals. Int J COPD. 2022;17:141–153. doi:10.2147/COPD.S348663

46. Augustine A, Bhat A, Vaishali K, Magazine R. Barriers to pulmonary rehabilitation – a narrative review and perspectives from a few stakeholders. Lung India. 2021;38(1):59–63. doi:10.4103/lungindia.lungindia_116_20

47. Padhye R, Sahasrabudhe SD, Orme MW, et al. Perspectives of patients with chronic respiratory diseases and medical professionals on pulmonary rehabilitation in Pune, India: Qualitative analysis. JMIR Form Res. 2023;7(1). doi:10.2196/45624

48. Rochester CL. Barriers to Pulmonary Rehabilitation. Respir Care. 2024;69(6):713–723. doi:10.4187/respcare.11656

49. Tweedy SM, Dutia IM, Caughey L, Demetriou B, Beckman EM, Cairney J. A systematic review of sample representativeness and homogeneity in exercise trials using group designs for people with cerebral palsy. JSAMS Plus. 2025;5. doi:10.1016/j.jsampl.2025.100103.

50. Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011;8(1):15–20. doi:10.3390/ijerph8010015

51. Zhaori G. Importance of sample size determination for randomized controlled clinical trials for coronavirus disease 2019 antiviral therapies. Pediatr Investig. 2024;8(1):7–11. doi:10.1002/ped4.12415

52. Stenson A, Chaplin EJ, Houchen-Wolloff L, Singh SJ. The impact of a baseline exercise test on confidence to perform subsequent incremental shuttle walk tests, walk at home, and manage breathlessness. J Cardiopulm Rehabil Prev. 2022;42(2):128–132.

Creative Commons License © 2026 The Author(s). This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.